ARCHIVES

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Mihich, Kennedy, Aust New Presidents; Loeb, Coltman, Cady Presidents Elect; Carbone Honored

May 29, 1987

Bill Requires NIH-Funded Researchers To Send Manuscripts To PubMed Central.

November 2, 2007

NCI-Approved Clinical Trials

December 30, 2005

Abstracts of Papers From ASCO Meeting

April 14, 1978

NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts

April 3, 1998

Final Issue of ‘76

December 10, 1976